Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit

Immunobiology

Volumn 216, Issue 4, 2011, Pages 447-456

  Odumosu, Oludare ^a   Payne, Kimberly ^a   Baez, Ineavely ^a   Jutzy, Jessica ^a   Wall, Nathan ^a   Langridge, William ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Adjuvant; Autoimmunity; Cholera toxin B (CTB); Dendritic cells; IDDM; Juvenile diabetes

Indexed keywords

AUTOANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHOLERA TOXIN B SUBUNIT; HYBRID PROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 23; PROINSULIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INOCULATION; INSULIN DEPENDENT DIABETES MELLITUS; MONOCYTE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; T LYMPHOCYTE; TH0 CELL; UMBILICAL CORD; UPREGULATION;

AUTOANTIGENS; CELLS, CULTURED; CHOLERA TOXIN; DENDRITIC CELLS; GENE ORDER; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; PROINSULIN; RECOMBINANT FUSION PROTEINS; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 79952193175     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.09.008     Document Type: Article

References (99)

1. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 2003, 85:85.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499.
3. Arakawa T., Chong D.K., Langridge W.H. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotechnol. 1998, 16:292.
4. Arakawa T., Yu J., Chong D.K., Hough J., Engen P.C., Langridge W.H. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 1998, 16:934.
5. Aspord C., Thivolet C. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 2002, 130:204.
6. Atkinson M.A., Leiter E.H. The NOD mouse model of type 1 diabetes: as good as it gets?. Nat. Med. 1999, 5:601.
7. Atkinson M.A., Maclaren N.K. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 1994, 331:1428.
8. Bergerot I., Ploix C., Petersen J., Moulin V., Rask C., Fabien N., Lindblad M., Mayer A., Czerkinsky C., Holmgren J., Thivolet C. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4610.
9. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 2006, 24:353.
10. Cardell S.L. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin. Exp. Immunol. 2006, 143:194.
11. Carter J.E., Yu J., Choi N.W., Hough J., Henderson D., He D., Langridge W.H. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis. Mol. Biotechnol. 2006, 32:1.
12. Connell T.D., Metzger D.J., Wang M., Jobling M.G., Holmes R.K. Initial studies of the structural signal for extracellular transport of cholera toxin and other proteins recognized by Vibrio cholerae. Infect. Immun. 1995, 63:4091.
13. D'Ambrosio A., Colucci M., Pugliese O., Quintieri F., Boirivant M. Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation. J. Leukoc. Biol. 2008, 84:661.
14. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 1991, 174:1209.
15. Denes B., Krausova V., Fodor N., Timiryasova T., Henderson D., Hough J., Yu J., Fodor I., Langridge W.H. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens. J. Immunother. 2005, 28:438.
16. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J. Clin. Endocrinol. Metab. 2008, 93:578.
17. Devaraj S., Glaser N., Griffen S., Wang-Polagruto J., Miguelino E., Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006, 55:774.
18. Eisenbarth G.S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 1986, 314:1360.
19. Elliott J.F., Qin H.Y., Bhatti S., Smith D.K., Singh R.K., Dillon T., Lauzon J., Singh B. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 1994, 43:1494.
20. Eriksson K., Holmgren J. Recent advances in mucosal vaccines and adjuvants. Curr. Opin. Immunol. 2002, 14:666.
21. Figdor C.G., de Vries I.J., Lesterhuis W.J., Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat. Med. 2004, 10:475.
22. George-Chandy A., Eriksson K., Lebens M., Nordstrom I., Schon E., Holmgren J. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect. Immun. 2001, 69:5716.
23. Gong Z., Jin Y., Zhang Y. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm. Vaccine 2007, 25:1444.
24. Gong Z., Long X., Pan L., Le Y., Liu Q., Wang S., Guo J., Xiao B., Zhou M., Mei D. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli. Protein Exp. Purif. 2009, 66:191.
25. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 2007, 8:1095.
26. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J. Leukoc. Biol. 2005, 77:3.
27. Hajishengallis G., Tapping R.I., Martin M.H., Nawar H., Lyle E.A., Russell M.W., Connell T.D. Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins. Infect. Immun. 2005, 73:1343.
28. Han B., Serra P., Yamanouchi J., Amrani A., Elliott J.F., Dickie P., Dilorenzo T.P., Santamaria P. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J. Clin. Invest. 2005, 115:1879.
29. Harizi H., Gualde N. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell. Mol. Immunol. 2006, 3:271.
30. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740.
31. Hoebe K., Jiang Z., Georgel P., Tabeta K., Janssen E., Du X., Beutler B. TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy. Curr. Pharm. Des. 2006, 12:4123.
32. Holmgren J., Adamsson J., Anjuere F., Clemens J., Czerkinsky C., Eriksson K., Flach C.F., George-Chandy A., Harandi A.M., Lebens M., Lehner T., Lindblad M., Nygren E., Raghavan S., Sanchez J., Stanford M., Sun J.B., Svennerholm A.M., Tengvall S. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol. Lett. 2005, 97:181.
33. Isomura I., Yasuda Y., Tsujimura K., Takahashi T., Tochikubo K., Morita A. Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity. Microbiol. Immunol. 2005, 49:79.
34. Itano A.A., McSorley S.J., Reinhardt R.L., Ehst B.D., Ingulli E., Rudensky A.Y., Jenkins M.K. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003, 19:47.
35. Jaeckel E., Klein L., Martin-Orozco N., von Boehmer H. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J. Exp. Med. 2003, 197:1635.
36. Jaeckel E., Lipes M.A., von Boehmer H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat. Immunol. 2004, 5:1028.
37. Kang B.Y., Kim T.S. Targeting cytokines of the interleukin-12 family in autoimmunity. Curr. Med. Chem. 2006, 13:1149.
38. Kanzler H., Barrat F.J., Hessel E.M., Coffman R.L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 2007, 13:552.
39. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984.
40. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., Hering B.J., Hafler D.A. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005, 435:224.
41. Kim N., Cheng K.C., Kwon S.S., Mora R., Barbieri M., Yoo T.J. Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease. Ann. Otol. Rhinol. Laryngol. 2001, 110:646.
42. Kobayashi M., Abiru N., Arakawa T., Fukushima K., Zhou H., Kawasaki E., Yamasaki H., Liu E., Miao D., Wong F.S., Eisenbarth G.S., Eguchi K. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes. J. Immunol. 2007, 179:2082.
43. LaFrance M.W., Kehinde L.E., Fullard R.J. Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay. Curr. Eye Res. 2008, 33:525.
44. Lavelle E.C., Jarnicki A., McNeela E., Armstrong M.E., Higgins S.C., Leavy O., Mills K.H. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J. Leukoc. Biol. 2004, 75:756.
45. Lavelle E.C., McNeela E., Armstrong M.E., Leavy O., Higgins S.C., Mills K.H. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 2003, 171:2384.
46. Lencer W.I., Constable C., Moe S., Jobling M.G., Webb H.M., Ruston S., Madara J.L., Hirst T.R., Holmes R.K. Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL. J. Cell Biol. 1995, 131:951.
47. Li T., Zhong J., Chen Y., Qiu X., Zhang T., Ma D., Han W. Expression of chemokine-like factor 1 is upregulated during T lymphocyte activation. Life Sci. 2006, 79:519.
48. Libby P., Nathan D.M., Abraham K., Brunzell J.D., Fradkin J.E., Haffner S.M., Hsueh W., Rewers M., Roberts B.T., Savage P.J., Skarlatos S., Wassef M., Rabadan-Diehl C. Report of the national heart, lung, and blood institute-national institute of diabetes and digestive and kidney diseases working group on cardiovascular complications of type 1 diabetes mellitus. Circulation 2005, 111:3489.
49. Liu H., MacKenzie-Graham A.J., Kim S., Voskuhl R.R. Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell tolerance. J. Neuroimmunol. 2001, 115:118.
50. Liu Q.L., Wang Y.S., Wang J.X. Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell lines. Hepatobiliary Pancreat. Dis. Int. 2009, 8:529.
51. Lodinova-Zadnikova R., Prokesova L., Tlaskalova H., Kocourkova I., Zizka J., Stranak Z. Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies. Ceska Gynekol. 2004, 69(Suppl 1):91.
52. Marinaro M., Staats H.F., Hiroi T., Jackson R.J., Coste M., Boyaka P.N., Okahashi N., Yamamoto M., Kiyono H., Bluethmann H., Fujihashi K., McGhee J.R. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 1995, 155:4621.
53. Merritt E.A., Sarfaty S., Chang T.T., Palmer L.M., Jobling M.G., Holmes R.K., Hol W.G. Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants. Structure 1995, 3:561.
54. Minderhoud I.M., Samsom M., Oldenburg B. What predicts mucosal inflammation in Crohn's disease patients?. Inflamm. Bowel Dis. 2007, 13:1567.
55. Okusawa T., Fujita M., Nakamura J., Into T., Yasuda M., Yoshimura A., Hara Y., Hasebe A., Golenbock D.T., Morita M., Kuroki Y., Ogawa T., Shibata K. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect. Immun. 2004, 72:1657.
56. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983, 222:1337.
57. Parrish Y.K., Baez I., Milford T.A., Benitez A., Galloway N., Rogerio J.W., Sahakian E., Kagoda M., Huang G., Hao Q.L., Sevilla Y., Barsky L.W., Zielinska E., Price M.A., Wall N.R., Dovat S., Payne K.J. IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J. Immunol. 2009, 182:4255.
58. Phipps P.A., Stanford M.R., Sun J.B., Xiao B.G., Holmgren J., Shinnick T., Hasan A., Mizushima Y., Lehner T. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur. J. Immunol. 2003, 33:224.
59. Piccinni M.P., Beloni L., Livi C., Maggi E., Scarselli G., Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 1998, 4:1020.
60. Potapova I.A., Gaudette G.R., Brink P.R., Robinson R.B., Rosen M.R., Cohen I.S., Doronin S.V. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 2007, 25:1761.
61. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 2001, 167:5067.
62. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:1036.
63. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183.
64. Roger T., Miconnet I., Schiesser A.L., Kai H., Miyake K., Calandra T. Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression. Biochem. J. 2005, 387:355.
65. Romagnani S. T-cell Subsets (Th1, Th2) and Cytokines in Autoimmunity 1998, Academic Press, 163 pp. 3rd ed.
66. Romagnani S. The Th1/Th2 paradigm and allergic disorders. Allergy 1998, 53:12.
67. Romagnani S., Kapsenberg M., Radbruch A., Adorini L. Th1 and Th2 cells. Res. Immunol. 1998, 149:871.
68. Roncarolo M.G., Levings M.K., Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 2001, 193:F5.
69. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2001, 2:947.
70. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4:469.
71. Shinomiya M., Fazle Akbar S.M., Shinomiya H., Onji M. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 1999, 117:38.
72. Shreedhar V.K., Kelsall B.L., Neutra M.R. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect. Immun. 2003, 71:504.
73. Sica A., Saccani A., Bottazzi B., Polentarutti N., Vecchi A., van Damme J., Mantovani A. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 2000, 164:762.
74. Silveira P.A., Grey S.T. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol. Metab. 2006, 17:128.
75. Sobel D.O., Yankelevich B., Goyal D., Nelson D., Mazumder A. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Diabetes 1998, 47:186.
76. Stanford M., Whittall T., Bergmeier L.A., Lindblad M., Lundin S., Shinnick T., Mizushima Y., Holmgren J., Lehner T. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin. Exp. Immunol. 2004, 137:201.
77. Stassen M., Fondel S., Bopp T., Richter C., Muller C., Kubach J., Becker C., Knop J., Enk A.H., Schmitt S., Schmitt E., Jonuleit H. Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur. J. Immunol. 2004, 34:1303.
78. Stassen M., Schmitt E., Jonuleit H. Human CD(4+)CD(25+) regulatory T cells and infectious tolerance. Transplantation 2004, 77:S23.
79. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997, 159:4772.
80. Sun J.B., Holmgren J., Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:10795.
81. Sun J.B., Li B.L., Czerkinsky C., Holmgren J. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit. Clin. Immunol. 2000, 97:130.
82. Sun J.B., Rask C., Olsson T., Holmgren J., Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:7196.
83. Sun J.B., Xiao B.G., Lindblad M., Li B.L., Link H., Czerkinsky C., Holmgren J. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. Int. Immunol. 2000, 12:1449.
84. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335.
85. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., Santamaria P., Locksley R.M., Krummel M.F., Bluestone J.A. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 2006, 7:83.
86. Tian B., Hao J., Zhang Y., Tian L., Yi H., O'Brien T.D., Sutherland D.E., Hering B.J., Guo Z. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Transplantation 2009, 87:198.
87. Tian J., Zekzer D., Lu Y., Dang H., Kaufman D.L. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J. Immunol. 2006, 176:2654.
88. Tinker J.K., Erbe J.L., Hol W.G., Holmes R.K. Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: mutational analysis and development of an in vitro assembly system. Infect. Immun. 2003, 71:4093.
89. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291.
90. Trembleau S., Germann T., Gately M.K., Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 1995, 16:383.
91. Trentham D.E., Dynesius-Trentham R.A., Orav E.J., Combitchi D., Lorenzo C., Sewell K.L., Hafler D.A., Weiner H.L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993, 261:1727.
92. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 2002, 115:2603.
93. van den Akker F., Sarfaty S., Twiddy E.M., Connell T.D., Holmes R.K., Hol W.G. Crystal structure of a new heat-labile enterotoxin, LT-IIb. Structure 1996, 4:665.
94. Wang Z.J., Zhang H., Chen X.L., Jin W.R., Cong Y.Q., Han B., Gu Y. Detection of IFN-gamma level in single CD8+ T cell. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2005, 21:72.
95. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 2001, 182:207.
96. Weiner H.L., Zhang Z.J., Khoury S.J., Miller A., al-Sabbagh A., Brod S.A., Lider O., Higgins P., Sobel R., Nussenblatt R.B., et al. Antigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens. Ann. N. Y. Acad. Sci. 1991, 636:227.
97. Yoon J.W., Jun H.S. Autoimmune destruction of pancreatic beta cells. Am. J. Ther. 2005, 12:580.
98. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10252.
99. Zorena K., Mysliwska J., Mysliwiec M., Balcerska A., Lipowski P., Raczynska K. Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus. Scand. J. Immunol. 2008, 67:204.